IJNST-2167-8685-S4-002.pdf (1.2 MB)
Nanoscale Cancer Therapeutics: Advances, Hurdles and Hopes
journal contribution
posted on 2017-12-07, 03:49 authored by Moffatt SCancer constitutes many heterogeneous diseases having varied
genetic and epigenetic abnormalities afflicting millions
of people globally. Despite substantial progress in elucidating
the complex molecular mechanisms underlying its cause, improvements
in terms of therapeutic index have largely remained
unchanged, while concomitant increases in the death rates have
been steadily climbing over the past five decades. Failure to
deliver effective treatment to cancer patients in the past has been
the inability to get enough of the drug in the right amounts and
form, and to the right place